 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.

Lupin, Glenmark recall drugs in US market: USFDA

The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA).

Lupin launches generic version of Oracea capsules in US

After witnessing consistent double-digit growth in branded formulations business in recent years, growth in the domestic formulation segment has moderated to high single digits

Steady US sales to bring a healthy quarter for pharma sector

Lupin share price | The share touched a 52-week high of Rs 1,703.80 and a 52-week low of Rs 655.75 on 11 March, 2024 and 17 April, 2023, respectively.

Lupin gains on launch of generic version of doxycycline capsules in US

Lupin recalled 26,352 bottles of Rifampin capsules, used in the treatment of tuberculosis

Lupin, Glenmark, Natco recall products from US markets

The share touched a 52-week high of Rs 1,704.25 on March 11, 2024 and a 52-week low of Rs 628 on March 31, 2023

Lupin share price fall on observation from USFDA

Indian generic companies have benefited from the continuing shortages and approval slowdown in the US.

Strong India growth, benign price erosion in the US drive Q3 earnings for Indian pharma

Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

Sun Pharma is recalling 54,960 bottles of Mesalamine Extended-Release Capsules, an anti-inflammatory medicine used to treat a type of bowel disease known as ulcerative colitis

Sun Pharma, Lupin, Alkem recall products from US market

Around 70% of stocks in Nifty MidCap 100 and Nifty SmallCap 100 indices witnessed a rise in mutual fund stakes in December 2023 quarter, according to Ace Equities data.

MFs raise stakes in 70% Nifty smallcap, midcap stocks in Q3, despite caution

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the business of producing, developing, and marketing a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. It operates through the following geographical segments: India, the United States of America, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.

Volume (M)	298,410.00
52-Wk High	1,704.25
52-Wk Low	658.50

LUPIN.NSE Lupin Ltd

About

Feed

News

Sentiment

Fundamentals